In an ever-changing market, where demand for effective drug delivery solutions continues to grow, Biodeal Pharmaceuticals Ltd.  has established itself as a strategic partner for the development and manufacture of Nasal sprays in India .

A Nasal Spray is a device used for nasal drug delivery in the nasal cavities. They are used to treat conditions, such as allergic rhinitis, cold, asthma, and central nervous system disorders. The device consists of drug substances in the form of a solution of excipients.

Global Nasal Spray Market Size is projected to grow from USD 15.82 billion in 2025 to USD 28.35 billion by 2035, growing at CAGR of 6% during the forecast period.

The rise in patient populations seeking non-invasive, patient –friendly therapies has spurred pharmaceutical investment in advanced nasal delivery systems.

Exploring Market Dynamics and Growth Avenues in the Nasal Sprays Industry

• Dominance of Nasal Steroid Sprays: Among product types, nasal steroid sprays continue to lead market growth due to their effectiveness in treating inflammation and allergies.
• Aqueous Formulation Leading the Market: The aqueous formulation is the most widely used, attributed to its safety, ease of application, and patient preference.
• Expansion into Non-Respiratory Treatments: With pharmaceutical companies exploring nasal drug delivery for broader therapeutic applications, the market is witnessing diversification and innovation, further fueling its expansion.

The advantages of inhalation dosage forms or inhalation preparations are: 

·         – Less systemic toxicity 

·         – Rapid onset of action

·         – Local drug delivery 

·         – Higher concentration of drug substances or API (active pharmaceutical ingredient) to target sites

·         – Potential of lower dosages & lower costs 

·         – Less wastage of medicines  

Biodeal Pharmaceuticals is among India’s leading manufacturer of Nasal Sprays catering to marquee international and domestic pharmaceutical companies.

Biodeal’s leading position in contract manufacturing and adherence to Global regulatory standards as aspects makes it a valuable and preferable CDMO for Nasal Sprays .

We provide exceptional analytical support throughout your nasal product’s lifecycle, from early development to commercialization.

As one of the few CDMOs offering holistic analytical services, we integrate expertise at every stage to help ensure optimal outcomes and accelerate your path to market.

As, nasal drug delivery Contract Development Manufacturing Organization (CDMO) we have available capacities and capabilities to produce first-class prescription nasal sprays for pharmaceutical customers worldwide.

The nasal drug delivery landscape is evolving rapidly, with the advent of new technologies and market demands driving innovation. Selecting the right CDMO is a critical decision that requires holistic evaluation of technical expertise, regulatory compliance, financial stability, customer service and cultural alignment.

As the industry continues to evolve, the role of CDMOs will become increasingly important in helping companies navigate the complexities of Nasal drug delivery.

Biodeal  brings innovation, scalability and seamless execution to every project, from formulation and clinical production to commercial manufacturing. 

Let Biodeal Pharmaceuticals be your CDMO partner that drives your Nasal programme from concept towards long-term success.